Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study

NCT07558057 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT07558057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07558057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study
Lead sponsor
Aarhus University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
March 31, 2034
Enrollment
225 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant lymphoma - lymphoplasmacytic, multiple myeloma (mm), lymphoma, large b-cell, diffuse (dlbcl), lymphoma